Einar Dale

Einar Dale

Auto-generated profile, based on publicly available information

Einar Dale

Department of Oncology, Oslo University Hospital, Norway

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 March 2021 in Physics in Medicine & Biology
Verified
Journal Article
Closed access
PDF file
AGAurora Rosvoll Groendahl
Aurora Rosvoll Groendahl
IKIngerid Skjei Knudtsen
Ingerid Skjei Knudtsen
BHBao Ngoc Huynh
Bao Ngoc Huynh
MMMartine Mulstad
Martine Mulstad
YMYngve Mardal Mardal Moe
Yngve Mardal Mardal Moe
CFCecilia Marie Futsæther
Cecilia Marie Futsæther
Target volume delineation is a vital but time-consuming and challenging part of radiotherapy, where the goal is to deliver sufficient dose to the target while reducing risks of side effects. For head and neck cancer (HNC) this is complicated by the complex anatomy of the head and neck region and the proximity of target volumes to organs at risk. The purpose of this study was to compare and evaluate conventional PET thresholding methods, six classical machine learning algorithms and a 2D U-Net convolutional neural network (CNN) for automatic gross tumor volume (GTV) segmentation of HNC in PET/CT images. For the latter two approaches the impact of single versus multimodality input on segmentation quality was also assessed. 197 patients were included in the study. The cohort was split into training and test sets (157 and 40 patients, respectively). Five-fold cross-validation was used on the training set for model comparison and selection. Manual GTV delineations represented the ground truth. Tresholding, classical machine learning and CNN segmentation models were ranked separately according to the cross-validation Sørensen–Dice similarity coefficient (Dice). PET thresholding gave a maximum mean Dice of 0.62, whereas classical machine learning resulted in maximum mean Dice scores of 0.24 (CT) and 0.66 (PET; PET/CT). CNN models obtained maximum mean Dice scores of 0.66 (CT), 0.68 (PET) and 0.74 (PET/CT). The difference in cross-validation Dice between multimodality PET/CT and single modality CNN models was significant (p ≤ 0.0001). The top-ranked PET/CT-based CNN model outperformed the best-performing thresholding and classical machine learning models, giving significantly better segmentations in terms of cross-validation and test set Dice, true positive rate, positive predictive value and surface distance-based metrics (p ≤ 0.0001). Thus, deep learning based on multimodality PET/CT input resulted in superior target coverage and less inclusion of surrounding normal tissue.

9 February 2021 in European Journal of Nuclear Medicine and Molecular Imaging
Verified
Journal Article
Open access
PDF file
YMYngve Mardal Moe
Yngve Mardal Moe
AGAurora Rosvoll Groendahl
Aurora Rosvoll Groendahl
OTOliver Tomic
Oliver Tomic
EDEinar Dale
Einar Dale
EMEirik Malinen
Eirik Malinen
CFCecilia Marie Futsæther
Cecilia Marie Futsæther
Purpose: Identification and delineation of the gross tumour and malignant nodal volume (GTV) in medical images are vital in radiotherapy. We assessed the applicability of convolutional neural networks (CNNs) for fully automatic delineation of the GTV from FDG-PET/CT images of patients with head and neck cancer (HNC). CNN models were compared to manual GTV delineations made by experienced specialists. New structure-based performance metrics were introduced to enable in-depth assessment of auto-delineation of multiple malignant structures in individual patients. Methods: U-Net CNN models were trained and evaluated on images and manual GTV delineations from 197 HNC patients. The dataset was split into training, validation and test cohorts (n= 142, n = 15 and n = 40, respectively). The Dice score, surface distance metrics and the new structure-based metrics were used for model evaluation. Additionally, auto-delineations were manually assessed by an oncologist for 15 randomly selected patients in the test cohort. Results: The mean Dice scores of the auto-delineations were 55%, 69% and 71% for the CT-based, PET-based and PET/CT-based CNN models, respectively. The PET signal was essential for delineating all structures. Models based on PET/CT images identified 86% of the true GTV structures, whereas models built solely on CT images identified only 55% of the true structures. The oncologist reported very high-quality auto-delineations for 14 out of the 15 randomly selected patients. Conclusions: CNNs provided high-quality auto-delineations for HNC using multimodality PET/CT. The introduced structure-wise evaluation metrics provided valuable information on CNN model strengths and weaknesses for multi-structure auto-delineation.

25 May 2017 in Radiation Oncology
Verified
Journal Article
Open access
PDF file
SJSafora Johansen
Safora Johansen
MNMathilde H. Norman
Mathilde H. Norman
EDEinar Dale
Einar Dale
CACecilie D. Amdal
Cecilie D. Amdal
TFTorbjørn Furre
Torbjørn Furre
JEJan F. Evensen
Jan F. Evensen
To evaluate the patterns of loco-regional recurrences in head and neck cancer patients Twenty-six out of 112 patients treated with primary or postoperative 3D CRT or IMRT for their primary and recurrent disease between 2007 and 2013 were included. The CT images of recurrent disease were rigidly registered with the primary CT images for each patient. To assess overlaps and overlap localization, the recurrence volume overlapping with the primary target volume was identified. For relapses occurring in the regional lymph nodes, the epicenter distance in recurrences and primary volumes and dose in recurrences were also identified. The recurrences were defined as in-field, marginal or out-of-field. The majority of the failures occurred within 1 year after completed primary treatment. The dose differences in recurrence volume were not statistically significant when patients were treated with IMRT or 3D CRT. Recurrence in 15/26 of the included patients occurred in the regional lymph nodes located fully or partly inside the primary target volume or the elective lymph node region. The majority of recurrences were recognized as in-field, independent of the primary treatment. Recurrence in the majority of the patients occurred in the regional lymph nodes located in high dose area. The cause of recurrence may be due to inadequate total dose in the primary treatment and/or lack of optimal primary diagnosis leading to inadequate primary target delineation.

1 November 2019 in Radiotherapy and Oncology
Verified
Journal Article
Closed access
JMJon Magne Moan
Jon Magne Moan
CACecilie Delphin Amdal
Cecilie Delphin Amdal
EMEirik Malinen
Eirik Malinen
JSJørund Graadal Svestad
Jørund Graadal Svestad
TBTrond Velde Bogsrud
Trond Velde Bogsrud
EDEinar Dale
Einar Dale

26 September 2016 in European Archives of Oto-Rhino-Laryngology
Verified
Journal Article
Closed access
PDF file
EDEinar Dale
Einar Dale
JMJon M. Moan
Jon M. Moan
TOTerje A. Osnes
Terje A. Osnes
TBTrond V. Bogsrud
Trond V. Bogsrud

6 January 2022 in Acta Oncologica
Verified
Journal Article
Closed access
MEMorten Egeberg Evensen
Morten Egeberg Evensen
TFTorbjørn Furre
Torbjørn Furre
EMEirik Malinen
Eirik Malinen
ALAyca Muftuler Løndalen
Ayca Muftuler Løndalen
EDEinar Dale
Einar Dale
Recurrences after radiochemotherapy for head and neck cancer (HNC) are often located within the region that received a high dose during the primary radiotherapy [1]. Moreover, there is an associati...